Rafael E Marques
Overview
Explore the profile of Rafael E Marques including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cambier S, Beretta F, Nooyens A, Metzemaekers M, Portner N, Kaes J, et al.
Cell Mol Life Sci
. 2024 Dec;
81(1):475.
PMID: 39625496
Elevated neutrophil counts in broncho-alveolar lavage (BAL) fluids of lung transplant (LTx) patients with chronic lung allograft dysfunction (CLAD) are associated with disease pathology. However, phenotypical characteristics of these cells...
2.
Plante K, Plante J, Azar S, Shinde D, Scharton D, Versiani A, et al.
Heliyon
. 2024 Mar;
10(6):e27934.
PMID: 38545168
Ilhéus virus (ILHV)() is an arthropod-borne virus (arbovirus) endemic to Central and South America and the Caribbean. First isolated in 1944, most of our knowledge derives from surveillance and seroprevalence...
3.
Machado T, Picorelli A, de Azevedo B, de Aquino I, Queiroz V, Rodrigues R, et al.
J Virol
. 2023 Dec;
97(12):e0130923.
PMID: 38092658
Giant viruses are noteworthy not only due to their enormous particles but also because of their gigantic genomes. In this context, a fundamental question has persisted: how did these genomes...
4.
Estofolete C, Versiani A, Dourado F, Milhim B, Pacca C, Silva G, et al.
PLoS Negl Trop Dis
. 2023 Nov;
17(11):e0011710.
PMID: 37943879
Background: The co-circulation of flaviviruses in tropical regions has led to the hypothesis that immunity generated by a previous dengue infection could promote severe disease outcomes in subsequent infections by...
5.
Brunetti N, Davanzo G, de Moraes D, Ferrari A, Souza G, Muraro S, et al.
Elife
. 2023 Jul;
12.
PMID: 37523305
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent of a major global outbreak of respiratory tract disease known as Coronavirus Disease 2019 (COVID-19). SARS-CoV-2 infects mainly lungs...
6.
de Souza W, Muraro S, Souza G, Amorim M, Sesti-Costa R, Mofatto L, et al.
Viruses
. 2021 Nov;
13(11).
PMID: 34834934
A SARS-CoV-2 B.1.1.7 variant of concern (VOC) has been associated with increased transmissibility, hospitalization, and mortality. This study aimed to explore the factors associated with B.1.1.7 VOC infection in the...
7.
Peroni L, Toscaro J, Canateli C, Tonoli C, de Olivera R, Benedetti C, et al.
Front Immunol
. 2021 Sep;
12:635701.
PMID: 34489923
Serological testing is a powerful tool in epidemiological studies for understanding viral circulation and assessing the effectiveness of virus control measures, as is the case of SARS-CoV-2, the pathogenic agent...
8.
Souza W, Amorim M, Sesti-Costa R, Coimbra L, Brunetti N, Toledo-Teixeira D, et al.
Lancet Microbe
. 2021 Jul;
2(10):e527-e535.
PMID: 34258603
Background: Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported...
9.
Rocco P, Silva P, Cruz F, Melo-Junior M, Tierno P, Moura M, et al.
Eur Respir J
. 2020 Dec;
58(1).
PMID: 33361100
Background: Nitazoxanide is widely available and exerts broad-spectrum antiviral activity . However, there is no evidence of its impact on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Methods: In...
10.
Loiola L, Batista M, Capeletti L, Mondo G, Rosa R, Marques R, et al.
J Colloid Interface Sci
. 2019 Jun;
553:540-548.
PMID: 31234127
Surface functionalization of silica nanoparticles (SiONPs) has been considered as a promising strategy to develop target-specific nanostructures. However, finding a chemical functionalization that can be used as an active targeting...